Taysha Gene Therapies, Inc. Common Stock (NASDAQ: TSHA) last traded at $6.09, down 0.33% on the session. The quote above updates while this page is open; the figures below are drawn from Taysha Gene Therapies, Inc. Common Stock’s own filings and are restated only when a new one is published.
Taysha Gene Therapies, Inc. Common Stock trades on NASDAQ under the ticker TSHA. Its market capitalisation is $1.98 billion.
Valuation measures for Taysha Gene Therapies, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.98B |
|---|---|
| Enterprise value | $1.61B |
| Price / sales | 361.77 |
| Price / book | 5.12 |
| Beta | 1.85 |
Trailing-twelve-month figures tagged in Taysha Gene Therapies, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $5.49M |
|---|---|
| Net income (TTM) | -$149.63M |
| EPS (TTM) | -$0.420 |
| Operating margin | -2792.32% |
| Return on equity | -38.64% |
| Cash | $455.41M |
Range and volume for TSHA over the past 52 weeks.
| 52-week high | $7.30 |
|---|---|
| 52-week low | $2.71 |
| Volume | 1.37M |
| Average volume | 3.13M |
| Previous close | $6.11 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.